NIH Using PARI's EFlow In HIV/AIDS Vaccine Research

... The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is currently conducting research using PARI's eFlow electronic nebulizer to study aerosol delivery of vaccines to the mucosa. This study evaluates immunogenicity of aerosolized adenovirus- and DNA-based vaccines delivered to the lungs to protect from HIV/AIDS and other viral diseases. [click link for full article] ...